DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Given the shared pathological mechanism between the loss of dystrophin and its associated proteins, such as sarcoglycans, this variant represented an attractive candidate modifier of human DMD, which was tested in the UDP severe dystrophinopathy cohort (n = 254) [45].